Learn More
Invitrogen™ Oxidized LDL Biosimilar Recombinant Monoclonal Antibody

Recombinant Monoclonal Antibody
Brand: Invitrogen™ MA559583
Description
For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °. This antibody can also be cross referenced by the term Okayama U. patent anti-oxLDL.
Low density lipoprotein (LDL) oxidative modification is one of the major processes involved in atherosclerosis along with other degenerative disorders. Oxidized LDL is preferentially accumulated by macrophages which become so called foam cells within the atheromatous plaque and contributes to the accumulation of cholesterol, typical of atherosclerosis.
Specifications
| Oxidized LDL Biosimilar | |
| Recombinant Monoclonal | |
| Unconjugated | |
| Human | |
| 100 μg | |
| Primary | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Lyophilized |
| ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance | |
| 1 mg/mL | |
| 25mM histidine with 8% sucrose, 0.01% Tween 80 and no preservative; pH 6.2 | |
| Protein A | |
| RUO | |
| Human | |
| Antibody | |
| IgG1 |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.